Get Started

LYEL

NASD Lyell Immunopharma, Inc.
Oct 30, 2026 · 2:38 AM ET EOD Market Closed

$11.31 ↑ +0.00 (+0.00%) Trading Up from the previous close of $11.31, $0.32 below the day’s high of $11.62

YTD change
-63.27%
vs 20-day SMA
+25.94%
vs 200-day SMA
-33.47%

Price ranges

Previous day
$9.84 $11.03
open $10.01 close $10.93
+$0.92 (+9.19%)
Today
$11.00 $11.62
open $11.00 now $11.31
+$0.31 (+2.77%)
Past week
$9.05 $11.03
from $9.41 now $11.31
+$1.90 (+20.14%)
Past month
$7.20 $11.03
from $9.79 now $11.31
+$1.52 (+15.47%)
This year
$7.20 $31.32
from $30.78 now $11.31
-$19.48 (-63.27%)

Price & Performance

-9.30 (-45.12%) / 6M

$6.44$11.60$16.76$21.92Apr 29Jul 30Oct 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 97.2% away from all-time highs of $396.80
  • LYEL is down 63% since the beginning of the year
  • LYEL is down 32% over the past 12 months
  • LYEL is up 15% over the past 1 month
  • 5% of all LYEL investors are betting against LYEL

LYEL reads very good: price sits above one of the two key moving averages, the 12-month move is -31.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.92
Earnings momentum +5.5% Quarterly EPS growth
Quarterly change +5.5%

Valuation

P/E ratio N/A
Enterprise value $97.9M
Beta 1.57

Balance sheet & scale

IncomeN/A
Revenue$27.0K
Cash$204.1M
Debt$46.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $277.1M

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.73 +1.97%
MRNA Moderna, Inc. $222.76 +4.01%
RVMD Revolution Medicines, Inc. $190.27 +0.82%
ROIV Roivant Sciences Ltd. $37.52 +1.10%
BNTX BioNTech SE Sponsored ADR $89.13 +1.30%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.